BANKIER ALAIN D (Chief Executive Officer) reported 1 transaction at NEXIEN BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 5/23/2018ACC: 0001214659-18-003971
DirectorOfficer· Chief Executive Officer
Since Jul 2018
0.00
Net shares
Net seller
$10.6K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
28K acquired · 28K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+28K
Price / share
$0.38
Trade value
$10.64K
% of position
1.3%
5/15/2018
2.23M→2.26M
Total
Net shares
+28K
Net value
$10.64K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/15/2018 | X · X | +28K | $0.38 | $10.64K | 1.3% | 2.23M | 2.26M |
| Total | +28K | $10.64K | ||||||
Derivative Transactions1
Class B Warrants (right to buy)
Direct
Converts to
Common Stock
28K shares
Shares
−28K
Strike price
0.38
Held after
0.00
Exercisable
—
5/15/2018
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Class B Warrants (right to buy) Direct | Common Stock28K shares | 5/15/2018 | X · X | −28K | 0.38 | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)0
No non-derivative holdings reported
Derivative Holdings (Post-Transaction)1
Class C Warrants (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
28K
Shares owned
28K
Exercise price
0.50
Expiration
—
Exercise window
—
Total
Underlying
28K
Owned
28K
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Class C Warrants (right to buy) Direct | Common Stock | 0.50 | — | — | 28K | 28K |
| Total | 28K | 28K | ||||